Holzer Phil M 4

What Happened

• Phil M. Holzer, SVP and Controller of Bristol Myers Squibb (BMY), had multiple equity awards vest/convert on March 10, 2026. The filing reports conversions (derivative exercises) totaling 6,191 shares (no cash exercise price) and the withholding of 1,358 shares to cover taxes (withholding valued at ~$81,656 at $60.13/share). The filing also records two grant/award entries totaling 12,578 derivative units and "other" dispositions of 2,438 shares (zero cash value).
• These were not open‑market purchases or sales of existing shares but vesting/conversion and grant actions. The conversions show $0.00 exercise price (typical for RSU/market-share-unit settlements), with shares withheld rather than a cash payment to satisfy tax obligations.

Key Details

• Transaction date: March 10, 2026; Form filed Mar 12, 2026 (timely).
• Converted/vested (M) shares: 6,191; Grant/award entries (A): 12,578 units.
• Shares withheld for taxes (F): 1,358 shares at $60.13 = $81,656 total.
• Other dispositions (J): 2,438 shares (reported at $0.00).
• Shares owned after the transactions: not specified in the provided data.
• Notable footnotes: vesting includes quarterly vesting of March 10, 2022 and 2023 grants (F1, F4), withholding for taxes (F3), and several awards are performance- or price‑linked subject to Board certification/payout factors (F2, F5–F11).

Context

• These entries reflect vesting/settlement of RSU/market-share and performance-share awards and routine tax-withholding (a common, non‑sentiment indicator). The M code reflects exercise/conversion of derivatives; F indicates shares withheld/used to pay taxes; A indicates grants/awards; J indicates other acquisitions/dispositions.
• No open‑market sales by the insider were reported in this filing — the transaction is a net settlement of awards rather than a sale intended as liquidity or investment signal.